Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John D Hainsworth, MD
SCRI Development Innovations, LLC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Florida Hospital Cancer Institute
Orlando, Florida, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Wellstar Cancer Research
Marietta, Georgia, United States
- Baptist Hospital East
Louisville, Kentucky, United States
- Norton Cancer Institute
Louisville, Kentucky, United States
- Research Medical Center
Kansas City, Missouri, United States
- Hematology Oncology Associates of Northern Nj
Morristown, New Jersey, United States
- Oncology Hematology Care
Cincinnati, Ohio, United States
- South Carolina Oncology Associates, Pa
Columbia, South Carolina, United States
- Spartanburg Regional Medical Center
Spartanburg, South Carolina, United States
- Tennessee Oncology, Pllc
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2006
- Primary completion
- 31 Oct 2013
- Completion
- 31 Oct 2013
- Last update posted
- 6 Jun 2022
- Registered enrollment
- 78
- Registry id
- NCT00392821
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.